2 Artificial Intelligence (AI) Stocks With Millionaire-Making Potential That Wall Street Is Overlooking

Airbnb reported $91 billion in full-year gross booking value for 2025 with over 9 million listings, yet its stock sits ~40% below five-year highs; the company has hired CTO Ahmad Al‑Dahle from Meta to pilot conversational AI search to boost discovery and personalization. Oscar Health posted an operating loss near $400 million in 2025, launched an OpenAI-powered chatbot called Oswell, and expects to achieve $250–$450 million of operating income after repriced plans. Both stories highlight AI-driven differentiation that could drive long-term revenue and earnings upside, but they are thematic developments likely to move individual stock sentiment modestly rather than trigger market-wide impacts.

Analysis

Embedding conversational discovery and LLM-driven personalization into consumer marketplaces is a demand multiplier, not just a cost-saver. A 5–15% lift in booking conversion or time-to-book compression materially leverages a platform with global supply: every incremental percentage point of conversion on a ~$90B GTV-like base converts to high-margin fee revenue growth within 12–24 months, and creates ordering power over adjacent distribution (metasearch, OTAs, local experiences).

In healthcare, LLM layers acting as front-line triage and administrative automation compress per-member service costs (call center, prior auth) while changing utilization patterns. Expect two offsetting forces over 12–36 months: lower non-emergent costs and faster care navigation reducing churn, but potentially higher total claim volumes from increased access and coding intensity; net margin impact depends on claims mix and how quickly actuarial assumptions re-price risk.

Second-order winners include cloud/GPU suppliers, NLU tooling vendors, and metasearch platforms that integrate proprietary behavioral signals. Regulatory and liability tail risks (privacy, clinical accuracy, consumer protection) create binary outcomes—fast scale with low regulatory friction (2–3x upside) or costly retrenchment and indemnity expenses that can wipe out near-term operating leverage. Near-term catalysts: product rollouts and quarterly mix improvements; medium-term outcome hinges on measurable MLR or take-rate improvements within 4 fiscal quarters.

Key Decisions for Investors

• Core long ABNB (2–3% portfolio weight) with a 12–36 month horizon: use 18–30 month call spreads (buy LEAP calls, sell higher strike) to capture platform conversion upside while capping premium. Risk/reward: asymmetric upside if conversion improves 5–10% over 18 months; downside from macro travel retrenchment—hedge with a 20% OTM put for drawdown protection.
• Pair trade 12-month: long ABNB / short MAR (or HLT) sized 1:0.6 by notional to express share-shift risk. Rationale: market share gains via better discovery should compress hotel ADR premium; target 20–30% relative outperformance if ABNB conversion improves. Stop-loss: cut if both tickers decline >25% on macro-driven travel collapse.
• Event-driven OSCR trade: buy OSCR equity and sell 9–12 month covered calls or buy protective puts (collar) to monetize elevated option skew. Timeframe: 12–24 months to allow re-priced premiums and margin recovery to materialize. Risk/reward: large upside if MLR normalizes and digital triage reduces costs; downside if claims remain elevated or regulatory issues emerge—limit position to 1–2% portfolio.
• Tactical overweight NVDA via 6–12 month call position (small allocation) as a convex hedge on AI demand acceleration supporting marketplace deployments. NVDA exposure pays if GPU cycle extends; if AI spend moderates, limit loss to option premium and keep position <1% portfolio.